Premature ovarian insufficiency: Procreative management and preventive strategies

Jennifer J. Chae-Kim, Larisa Gavrilova-Jordan

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Premature ovarian insufficiency (POI) is the loss of normal hormonal and reproductive function of ovaries in women before age 40 as the result of premature depletion of oocytes. The incidence of POI increases with age in reproductive-aged women, and it is highest in women by the age of 40 years. Reproductive function and the ability to have children is a defining factor in quality of life for many women. There are several methods of fertility preservation available to women with POI. Procreative management and preventive strategies for women with or at risk for POI are reviewed.

Original languageEnglish (US)
Article number2
JournalBiomedicines
Volume7
Issue number1
DOIs
StatePublished - Mar 1 2019

Fingerprint

Fertility Preservation
Oocytes
Ovary
Quality of Life
Incidence

Keywords

  • Donor oocyte
  • Fertility preservation
  • In vitro fertilization
  • Premature ovarian insufficiency

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Premature ovarian insufficiency : Procreative management and preventive strategies. / Chae-Kim, Jennifer J.; Gavrilova-Jordan, Larisa.

In: Biomedicines, Vol. 7, No. 1, 2, 01.03.2019.

Research output: Contribution to journalReview article

@article{b605a75578c943dca89ed98115e7d765,
title = "Premature ovarian insufficiency: Procreative management and preventive strategies",
abstract = "Premature ovarian insufficiency (POI) is the loss of normal hormonal and reproductive function of ovaries in women before age 40 as the result of premature depletion of oocytes. The incidence of POI increases with age in reproductive-aged women, and it is highest in women by the age of 40 years. Reproductive function and the ability to have children is a defining factor in quality of life for many women. There are several methods of fertility preservation available to women with POI. Procreative management and preventive strategies for women with or at risk for POI are reviewed.",
keywords = "Donor oocyte, Fertility preservation, In vitro fertilization, Premature ovarian insufficiency",
author = "Chae-Kim, {Jennifer J.} and Larisa Gavrilova-Jordan",
year = "2019",
month = "3",
day = "1",
doi = "10.3390/biomedicines7010002",
language = "English (US)",
volume = "7",
journal = "Biomedicines",
issn = "2227-9059",
publisher = "MDPI AG",
number = "1",

}

TY - JOUR

T1 - Premature ovarian insufficiency

T2 - Procreative management and preventive strategies

AU - Chae-Kim, Jennifer J.

AU - Gavrilova-Jordan, Larisa

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Premature ovarian insufficiency (POI) is the loss of normal hormonal and reproductive function of ovaries in women before age 40 as the result of premature depletion of oocytes. The incidence of POI increases with age in reproductive-aged women, and it is highest in women by the age of 40 years. Reproductive function and the ability to have children is a defining factor in quality of life for many women. There are several methods of fertility preservation available to women with POI. Procreative management and preventive strategies for women with or at risk for POI are reviewed.

AB - Premature ovarian insufficiency (POI) is the loss of normal hormonal and reproductive function of ovaries in women before age 40 as the result of premature depletion of oocytes. The incidence of POI increases with age in reproductive-aged women, and it is highest in women by the age of 40 years. Reproductive function and the ability to have children is a defining factor in quality of life for many women. There are several methods of fertility preservation available to women with POI. Procreative management and preventive strategies for women with or at risk for POI are reviewed.

KW - Donor oocyte

KW - Fertility preservation

KW - In vitro fertilization

KW - Premature ovarian insufficiency

UR - http://www.scopus.com/inward/record.url?scp=85063574731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063574731&partnerID=8YFLogxK

U2 - 10.3390/biomedicines7010002

DO - 10.3390/biomedicines7010002

M3 - Review article

AN - SCOPUS:85063574731

VL - 7

JO - Biomedicines

JF - Biomedicines

SN - 2227-9059

IS - 1

M1 - 2

ER -